Prudential Financial’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77M Sell
307,050
-18,300
-6% -$289K ﹤0.01% 1180
2025
Q4
$5.93M Sell
325,350
-116,480
-26% -$1.96M 0.01% 842
2025
Q3
$6.48M Sell
441,830
-56,870
-11% -$975K 0.01% 803
2025
Q2
$9.08M Buy
498,700
+665
+0.1% +$13.6K 0.01% 674
2025
Q1
$9.88M Sell
498,035
-26,395
-5% -$456K 0.01% 593
2024
Q4
$8.99M Buy
524,430
+5,897
+1% +$111K 0.01% 653
2024
Q3
$10.4M Buy
518,533
+122,959
+31% +$1.91M 0.01% 666
2024
Q2
$4.42M Buy
395,574
+359,238
+989% +$3.01M 0.01% 984
2024
Q1
$240K Buy
36,336
+22,746
+167% +$124K ﹤0.01% 2417
2023
Q4
$61.4K Buy
13,590
+550
+4% +$2.04K ﹤0.01% 2533
2023
Q3
$46.7K Hold
13,040
﹤0.01% 2508
2023
Q2
$48.1K Buy
13,040
+980
+8% +$3.63K ﹤0.01% 2539
2023
Q1
$39.9K Buy
12,060
+310
+3% +$1.07K ﹤0.01% 2520
2022
Q4
$45.6K Sell
11,750
-3,700
-24% -$11.4K ﹤0.01% 2500
2022
Q3
$38K Sell
15,450
-17,200
-53% -$41.3K ﹤0.01% 2584
2022
Q2
$65K Buy
+32,650
New +$64.2K ﹤0.01% 2554
2021
Q2
Sell
-12,909
Closed -$23K 2548
2021
Q1
$23K Buy
12,909
+1,980
+18% +$4.53K ﹤0.01% 2477
2020
Q4
$21K Hold
10,929
﹤0.01% 2436
2020
Q3
$26K Buy
+10,929
New +$30K ﹤0.01% 2409

Other funds holding ADMA

Prudential Financial's ADMA Position: Q1 2026 in Review

Prudential Financial reduced its ADMA Biologics (ADMA) stake by 5.6% in Q1 2026, selling an estimated $289K and leaving 307,050 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1180.

Prudential Financial first reported a position in ADMA in Q3 2020 and has held it in 19 quarters since. The position peaked at $10.4M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Prudential Financial held 307,050 shares of ADMA Biologics worth $2.77M as of Q1 2026.
  • Prudential Financial sold 18,300 ADMA Biologics shares in Q1 2026, an estimated $289K.
  • ADMA Biologics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1180 holding.
  • Prudential Financial first reported a position in ADMA Biologics in Q3 2020 and has held it in 19 quarters since.
  • Prudential Financial's ADMA Biologics position peaked at $10.4M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.